FDA IND approval for Zn-DTPA, new clinical agent for decorporation therapy of actinides.

FDA approval of doxylamine-pyridoxine therapy for use in pregnancy.

FDA approves new agent for multiple myeloma.

FDA hastens approval of 'important' new drugs.

Ceritinib gains FDA approval for lung cancer.

FDA Approval Summary: Ramucirumab for Gastric Cancer.

FDA committee recommends approval for "female Viagra".

JAMA patient page. FDA approval of new drugs.

FDA declines approval of testosterone drug for third time.

FDA approval of paroxetine for menopausal hot flushes.

ClinicalTrials.gov and Drugs@FDA: A Comparison of Results Reporting for New Drug Approval Trials.

New FDA drug approval policies and HIV vaccine development.

First FDA approval of neoadjuvant therapy for breast cancer: pertuzumab for the treatment of patients with HER2-positive breast cancer.

Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012.

FDA advisers recommend approval of biosimilar filgrastim.

Drug development and FDA approval, 1938-2013.

FDA approval of bedaquiline--the benefit-risk balance for drug-resistant tuberculosis.

Assessing the cost burden of United States FDA-mandated post-approval studies for medical devices.

Gene therapy for cancer: regulatory considerations for approval.

Cosentyx (Secukinumab): First IL-17A Antagonist Receives FDA Approval for Moderate-to-Severe Plaque Psoriasis.

FDA Approval of Flibanserin--Treating Hypoactive Sexual Desire Disorder.

Opdivo (Nivolumab): Second PD-1 Inhibitor Receives FDA Approval for Unresectable or Metastatic Melanoma.

Interactive perspective: drug development and FDA approval, 1938-2013.

Depo-Provera. Controversial contraceptive wins approval from FDA panel.

Developing a physiologically based approach for modeling plutonium decorporation therapy with DTPA.

Suggest Documents

FDA approval of doxylamine-pyridoxine therapy for use in pregnancy.

FDA approves new agent for multiple myeloma.

FDA hastens approval of 'important' new drugs.

Ceritinib gains FDA approval for lung cancer.

FDA Approval Summary: Ramucirumab for Gastric Cancer.

FDA committee recommends approval for "female Viagra".

JAMA patient page. FDA approval of new drugs.

FDA declines approval of testosterone drug for third time.

FDA approval of paroxetine for menopausal hot flushes.

ClinicalTrials.gov and Drugs@FDA: A Comparison of Results Reporting for New Drug Approval Trials.

New FDA drug approval policies and HIV vaccine development.

First FDA approval of neoadjuvant therapy for breast cancer: pertuzumab for the treatment of patients with HER2-positive breast cancer.

Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012.

FDA advisers recommend approval of biosimilar filgrastim.

Drug development and FDA approval, 1938-2013.

FDA approval of bedaquiline--the benefit-risk balance for drug-resistant tuberculosis.

Assessing the cost burden of United States FDA-mandated post-approval studies for medical devices.

Gene therapy for cancer: regulatory considerations for approval.

Cosentyx (Secukinumab): First IL-17A Antagonist Receives FDA Approval for Moderate-to-Severe Plaque Psoriasis.

FDA Approval of Flibanserin--Treating Hypoactive Sexual Desire Disorder.

Opdivo (Nivolumab): Second PD-1 Inhibitor Receives FDA Approval for Unresectable or Metastatic Melanoma.

Interactive perspective: drug development and FDA approval, 1938-2013.

Depo-Provera. Controversial contraceptive wins approval from FDA panel.

Developing a physiologically based approach for modeling plutonium decorporation therapy with DTPA.

FDA IND approval for Zn-DTPA, new clinical agent for decorporation therapy of actinides.

Recommend Documents

Follow Us